Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.
NCT ID: NCT05634655
Last Updated: 2022-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2022-01-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of G-quadruplex DNA Methylation in Cancer
NCT06537063
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
NCT01005654
Implementation of the Methylome in the Characterization of Solid Tumors
NCT07268066
Epigenetic Changes in Head and Neck Cancer
NCT04260074
DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma
NCT02159339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
invasive PAs
no interventions between two groups
no interventions between two groups
non-invasive PAs
no interventions between two groups
no interventions between two groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no interventions between two groups
no interventions between two groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2ndAffiliated Hospital, School of Medicine
Hanzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0765
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.